Your session is about to expire
← Back to Search
Decision Aid Web Tool for Kidney Cancer
Study Summary
This trial is to study how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 or older with a kidney tumor no larger than 4 cm.You have appointments for regular medical check-ups at the NYU Urology Department.My cancer is at stage IV.
- Group 1: Decision Aid (DA) Web Tool
- Group 2: Institutional Pamphlet
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum allotment of participants for this experiment?
"Affirmative. According to clinicaltrials.gov, this research project is still recruiting participants and was first posted on September 12th 2022. The most recent update occurred November 4th of the same year and 213 individuals are being sought at a single site."
Are there any open spots remaining for the participants of this experiment?
"Affirmative. Information found on clinicaltrials.gov shows that this medical trial, which first went live on September 12th 2022, is actively seeking participants. A total of 213 patients must be sourced from a single location."
Share this study with friends
Copy Link
Messenger